Pathway-based association analyses identified TRAIL pathway for osteoporotic fractures

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Zhang, Yin Ping ^a   Liu, Yao Zhong ^b   Guo, Yan ^c   Liu, Xiao Gang ^c   Xu, Xiang Hong ^c   Guo, Yan Fang ^c   Chen, Yuan ^c   Zhang, Feng ^a   Pan, Feng ^c   Zhu, Xue Zhen ^d   Deng, Hong Wen ^b,c,d  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b TULANE UNIVERSITY   (United States)

^c XI'AN JIAOTONG UNIVERSITY   (China)

^d UNIVERSITY OF SHANGHAI FOR SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CFLAR GENE; CHINESE; CONTROLLED STUDY; FEMALE; FRAGILITY FRACTURE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENOME ANALYSIS; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; NFKB1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TNFRSF10B GENE; TNFRSF11A GENE; TNFSF10 GENE; TNFSF11 GENE; TRAF3 GENE; TRAIL GENE; AGED; GENETIC PREDISPOSITION; GENETICS; MALE; SIGNAL TRANSDUCTION;

TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; OSTEOPOROTIC FRACTURES; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 79960107144     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021835     Document Type: Article

References (40)

1. Cooper C, Campion G, Melton LJ 3rd, (1992) Hip fractures in the elderly: a world-wide projection. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2: 285-289.
2. Gullberg B, Johnell O, Kanis JA, (1997) World-wide projections for hip fracture. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 7: 407-413.
3. Tranah GJ, Taylor BC, Lui LY, Zmuda JM, Cauley JA, et al. (2008) Genetic variation in candidate osteoporosis genes, bone mineral density, and fracture risk: the study of osteoporotic fractures. Calcified tissue international 83: 155-166.
4. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, et al. (2008) Multiple genetic loci for bone mineral density and fractures. The New England journal of medicine 358: 2355-2365.
5. Curtis RK, Oresic M, Vidal-Puig A, (2005) Pathways to the analysis of microarray data. Trends in biotechnology 23: 429-435.
6. Zhang L, Guo YF, Liu YZ, Liu YJ, Xiong DH, et al. (2010) Pathway-based genome-wide association analysis identified the importance of regulation-of-autophagy pathway for ultradistal radius BMD. J Bone Miner Res 25 (7): 1572-80.
7. Chen Y, Xiong DH, Guo YF, Pan F, Zhou Q, et al. (2010) Pathway-based genome-wide association analysis identified the importance of EphrinA-EphR pathway for femoral neck bone geometry. Bone 46: 129-136.
8. Vaira S, Alhawagri M, Anwisye I, Kitaura H, Faccio R, et al. (2008) RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. The Journal of clinical investigation 118: 2088-2097.
9. Sanjay A, Houghton A, Neff L, DiDomenico E, Bardelay C, et al. (2001) Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. The Journal of cell biology 152: 181-195.
10. Yao GQ, Sun BH, Insogna KL, Weir EC, (2000) Nuclear factor-kappaB p50 is required for tumor necrosis factor-alpha-induced colony-stimulating factor-1 gene expression in osteoblasts. Endocrinology 141: 2914-2922.
11. Ross PD, (1998) Risk factors for osteoporotic fracture. Endocrinol Metab Clin North Am 27: 289-301.
12. Di X, Matsuzaki H, Webster TA, Hubbell E, Liu G, et al. (2005) Dynamic model based algorithms for screening and genotyping over 100 K SNPs on oligonucleotide microarrays. Bioinformatics (Oxford, England) 21: 1958-1963.
13. Rabbee N, Speed TP, (2006) A genotype calling algorithm for affymetrix SNP arrays. Bioinformatics (Oxford, England) 22: 7-12.
14. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
15. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102: 15545-15550.
16. Pritchard JK, Stephens M, Donnelly P, (2000) Inference of population structure using multilocus genotype data. Genetics 155: 945-959.
17. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-909.
18. Devlin B, Roeder K, (1999) Genomic control for association studies. Biometrics 55: 997-1004.
19. Colucci S, Brunetti G, Cantatore FP, Oranger A, Mori G, et al. (2007) The death receptor DR5 is involved in TRAIL-mediated human osteoclast apoptosis. Apoptosis 12: 1623-1632.
20. Feng X, (2005) Regulatory roles and molecular signaling of TNF family members in osteoclasts. Gene 350: 1-13.
21. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, et al. (1996) Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. The Journal of biological chemistry 271: 12687-12690.
22. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, et al. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682.
23. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, et al. (1997) The receptor for the cytotoxic ligand TRAIL. Science (New York, NY) 276: 111-113.
24. Chamoux E, Houde N, L'Eriger K, Roux S, (2008) Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway. J Cell Physiol 216: 536-542.
25. Zauli G, Rimondi E, Nicolin V, Melloni E, Celeghini C, et al. (2004) TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF. Blood 104: 2044-2050.
26. Tschopp J, Irmler M, Thome M, (1998) Inhibition of Fas death signals by FLIPs. Current Opinion in Immunology 10: 552-558.
27. Sedger LM, Glaccum MB, Schuh JCL, Kanaly ST, Williamson E, et al. (2002) Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice. European Journal of Immunology 32: 2246-2254.
28. Yen ML, Tsai HF, Wu YY, Hwa HL, Lee BH, et al. (2008) TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells. Molecular Immunology 45: 2205-2213.
29. Hsu PN, Huang SC, (2009) TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells via TRAF-6 dependent pathway. The Journal of Immunology 182: 14.
30. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
31. Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, et al. (1998) Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. The Journal of biological chemistry 273: 14363-14367.
32. Grimaud E, Soubigou L, Couillaud S, Coipeau P, Moreau A, et al. (2003) Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am J Pathol 163: 2021-2031.
33. Xu JK, Wu HF, Ang ESM, Yip K, Woloszyn M, et al. (2009) NF-kappa B modulators in osteolytic bone diseases. Cytokine & Growth Factor Reviews 20: 7-17.
34. Wakeyama H, Akiyama T, Takahashi K, Amano H, Kadono Y, et al. (2007) Negative feedback loop in the Bim-caspase-3 axis regulating apoptosis and activity of osteoclasts. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 22: 1631-1639.
35. Hauer J, Pèuschner S, Ramakrishnan P, Simon U, Bongers M, et al. (2005) TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. Proceedings of the National Academy of Sciences of the United States of America 102: 2874-2879.
36. Darnay BG, Ni J, Moore PA, Aggarwal BB, (1999) Activation of NF-kappa B by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappa B-inducing kinase- Identification of a novel TRAF6 interaction motif. Journal of Biological Chemistry 274: 7724-7731.
37. Mogi M, Ozeki N, Nakamura H, Togari A, (2004) Dual roles for NF-kappa B activation in osteoblastic cells by serum deprivation: osteoblastic apoptosis and cell-cycle arrest. Bone 35: 507-516.
38. Thomas DC, Witte JS, (2002) Point: population stratification: a problem for case-control studies of candidate-gene associations? Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 11: 505-512.
39. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, et al. (2007) Replicating genotype-phenotype associations. Nature 447: 655-660.
40. Pritchard JK, Stephens M, Donnelly P, (2000) Inference of population structure using multilocus genotype data. Genetics 155: 945-959.